Weber Barbara

SEC CIK: 0001800670

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $374.4K and no purchases.

Current role at each company

PBLS Parabilis Medicines, Inc.Directoras of Jun 11, 2026
TNGX Tango Therapeutics, Inc.Director, Executive Chairas of Feb 4, 2026
RVMD Revolution Medicines, Inc.Directoras of Oct 10, 2024

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $374.4K; 1 filing
Net: −$374.4K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Weber Barbara as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

TNGX Tango Therapeutics, Inc.

Director, Executive Chair3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Feb 4, 2026 (view filing)	Feb 3	1 day	Weber BarbaraDirector, Executive Chair	SSale	−30.5K	$12.27	−$374.4K	−1.8%1.63M after	2 lots
Feb 6, 2025 (view filing)	Feb 4-5	2 days	Weber BarbaraChief Executive Officer	SSale	−18.8K	$3.07	−$57.7K	−1.1%1.62M after	2 lots
Feb 8, 2024 (view filing)	Feb 6-7	2 days	Weber BarbaraChief Executive Officer	SSale	−9.14K	$12.59	−$115.0K	−0.6%1.54M after	2 lots

RVMD Revolution Medicines, Inc.

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Oct 10, 2024 (view filing)	Oct 8	2 days	Weber BarbaraDirector	SSale	−5.20K	$48.02	−$249.7K	−28.5%13.1K after	10b5-1
Sep 6, 2023 (view filing)	Sep 1	5 days	Weber BarbaraDirector	SSale	−15.0K	$35.07	−$526.0K	−48.7%15.8K after